Spread through Air Spaces (STAS) in Solitary Pulmonary Metastases from Colorectal Cancer (CRC).


Journal

The Thoracic and cardiovascular surgeon
ISSN: 1439-1902
Titre abrégé: Thorac Cardiovasc Surg
Pays: Germany
ID NLM: 7903387

Informations de publication

Date de publication:
03 2023
Historique:
pubmed: 19 10 2022
medline: 14 3 2023
entrez: 18 10 2022
Statut: ppublish

Résumé

Spread through air spaces (STAS) is a recently described route of tumor invasion associated with poor prognosis in primary lung cancer. Aim of this study was to investigate the presence of STAS and to assess its prognostic significance in patients undergoing pulmonary metastasectomy (PM) for solitary metastases from colorectal cancer (CRC). All 49 CRC patients (30 male and 19 female, median age 66 years) who underwent PM between January 2008 and December 2015 were retrospectively analyzed. STAS was identified in 26.5% ( We identified STAS as a frequent finding in resected CRC lung metastases and found insignificant association with outcome.

Sections du résumé

BACKGROUND
Spread through air spaces (STAS) is a recently described route of tumor invasion associated with poor prognosis in primary lung cancer. Aim of this study was to investigate the presence of STAS and to assess its prognostic significance in patients undergoing pulmonary metastasectomy (PM) for solitary metastases from colorectal cancer (CRC).
MATERIALS AND METHODS
All 49 CRC patients (30 male and 19 female, median age 66 years) who underwent PM between January 2008 and December 2015 were retrospectively analyzed.
RESULTS
STAS was identified in 26.5% (
CONCLUSION
We identified STAS as a frequent finding in resected CRC lung metastases and found insignificant association with outcome.

Identifiants

pubmed: 36257546
doi: 10.1055/s-0042-1757632
pmc: PMC9998148
doi:

Substances chimiques

xylometazoline WPY40FTH8K

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

138-144

Informations de copyright

The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Déclaration de conflit d'intérêts

None declared.

Références

Am J Surg Pathol. 2017 Sep;41(9):1226-1230
pubmed: 28622180
Ann Thorac Surg. 2019 Feb;107(2):631-649
pubmed: 30476477
Stud Health Technol Inform. 2012;179:250-6
pubmed: 22925805
Am J Surg Pathol. 2013 Feb;37(2):287-94
pubmed: 23095504
Medicina (Kaunas). 2019 Dec 30;56(1):
pubmed: 31906017
Ann Thorac Surg. 2010 Aug;90(2):398-404
pubmed: 20667318
Ann Thorac Surg. 2005 Sep;80(3):1040-5
pubmed: 16122482
Lung Cancer. 2020 Aug;146:127-133
pubmed: 32534331
J Gastrointest Surg. 2009 Apr;13(4):642-8
pubmed: 19082673
J Thorac Oncol. 2015 Sep;10(9):1243-1260
pubmed: 26291008
Ann Thorac Surg. 2006 Feb;81(2):448-54
pubmed: 16427829
Oncotarget. 2015 Nov 17;6(36):38658-66
pubmed: 26484417
Ann Am Thorac Soc. 2017 Jan;14(1):118-123
pubmed: 27854541
Int J Clin Exp Med. 2015 Aug 15;8(8):13571-7
pubmed: 26550296
Thorax. 2014 Oct;69(10):946-9
pubmed: 24415715
Am J Surg Pathol. 2015 Jun;39(6):793-801
pubmed: 25723114
Ann Thorac Surg. 2007 Jul;84(1):324-38
pubmed: 17588454
Ann Thorac Surg. 2004 May;77(5):1786-91
pubmed: 15111187
Lung Cancer. 2020 Nov;149:61-67
pubmed: 32979633
J Thorac Oncol. 2022 Jan;17(1):e1-e4
pubmed: 34930611
J Thorac Oncol. 2015 May;10(5):806-814
pubmed: 25629637
J Thorac Cardiovasc Surg. 2019 Apr;157(4):1648-1655
pubmed: 30635188

Auteurs

Mohamed Anwar Haj Khalaf (MA)

Division of Thoracic Surgery, Erlangen University Hospital, Erlangen, Germany.
Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.

Horia Sirbu (H)

Division of Thoracic Surgery, Erlangen University Hospital, Erlangen, Germany.
Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.

Arndt Hartmann (A)

Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Pathology Institute, Erlangen University Hospital, Erlangen, Germany.

Abbas Agaimy (A)

Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Pathology Institute, Erlangen University Hospital, Erlangen, Germany.

Wojciech Dudek (W)

Division of Thoracic Surgery, Erlangen University Hospital, Erlangen, Germany.
Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.

Mostafa Higaze (M)

Division of Thoracic Surgery, Erlangen University Hospital, Erlangen, Germany.
Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.

Ralf Rieker (R)

Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Pathology Institute, Erlangen University Hospital, Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH